Document Detail


Women and omega-3 Fatty acids.
MedLine Citation:
PMID:  15385858     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Omega-3 fatty acids (omega-3 FA) are constituents of the membranes of all cells in the body and are precursors of locally produced hormones, eicosanoids, which are important in the prevention and treatment of various diseases, especially in women. Omega-3 FA are of interest in some of the most common conditions affecting women. One mechanism underlying dysmenorrhea is a disturbed balance between antiinflammatory, vasodilator eicosanoids derived from omega-3 FA and proinflammatory, vasoconstrictor eicosanoids derived from omega-6 FA. Increased intake of omega-3 FA can reverse the symptoms in this condition by decreasing the amount of omega-6 FA in cell membranes. An increased prostacyclin/thromboxane ratio induced by omega-3 FA can facilitate pregnancy in women with infertility problems by increasing uterine blood flow. Supplementation with omega-3 FA during pregnancy lowers the risk of premature birth and can increase the length of pregnancy and birth weight by altering the balance of eicosanoids involved in labor and promote fetal growth by improving placental blood flow. Intake of omega-3 FA during pregnancy and breast feeding may facilitate the child's brain development. There is also some evidence that supplementation with omega-3 FA might help to prevent preeclampsia, postpartum depression, menopausal problems, postmenopausal osteoporosis, and breast cancer. Furthermore, because elevated triglyceride levels are associated with cardiovascular disease, especially in women; and because omega-3 FA have powerful effects on triglycerides, women in particular gain from an increased intake of these fatty acids. This is especially important in women receiving hormone therapy, which can increase triglyceride levels. The quality of the omega-3 FA preparation is important. It should have an appropriate antioxidant content not to induce lipid peroxidation, and its content of dioxin and polychlorinated biphenyls (PCBs) should be well below the established safe limit.
Authors:
Pia Saldeen; Tom Saldeen
Related Documents :
11553658 - Self reported alcohol intake in pregnancy: comparison between four methods.
3703408 - Genetic counseling for teratogen exposure.
8950288 - Cocaine abuse in pregnancy: its evaluation through hair analysis of pathological new-bo...
596498 - Moderate alcohol use during pregnancy and decreased infant birth weight.
23008638 - Sero-prevalence of toxoplasmosis in pregnant mothers and new born infants in eastern pr...
21838168 - Conjoined twins in a spontaneous trichorionic quadruplet pregnancy: a case report.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Obstetrical & gynecological survey     Volume:  59     ISSN:  0029-7828     ISO Abbreviation:  Obstet Gynecol Surv     Publication Date:  2004 Oct 
Date Detail:
Created Date:  2004-09-23     Completed Date:  2004-12-30     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  0401007     Medline TA:  Obstet Gynecol Surv     Country:  United States    
Other Details:
Languages:  eng     Pagination:  722-30; quiz 745-6     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Malmö University Hospital, University of Lund, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Brain / embryology,  growth & development
Breast Neoplasms / diet therapy,  etiology,  prevention & control
Cardiovascular Diseases / prevention & control
Depression, Postpartum / etiology
Diabetes, Gestational / prevention & control
Dysmenorrhea / etiology
Fatty Acids, Omega-3 / administration & dosage,  metabolism*,  standards
Fatty Acids, Omega-6 / adverse effects,  metabolism
Female
Hormone Replacement Therapy / adverse effects
Humans
Infertility / etiology
Menopause / metabolism
Obstetric Labor, Premature / etiology
Osteoporosis / prevention & control
Pre-Eclampsia / prevention & control
Pregnancy
Triglycerides / blood
Women's Health*
Chemical
Reg. No./Substance:
0/Fatty Acids, Omega-3; 0/Fatty Acids, Omega-6; 0/Triglycerides

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Exercise and urinary incontinence in women.
Next Document:  Determination of maternal body composition in pregnancy and its relevance to perinatal outcomes.